Case Study Analysis and Solutions

Case ID: 214078

Abstract:
Case Solution & Analysis for Mylan Laboratories' Proposed Merger with King Pharmaceutical by Lucy White, Matt Kozlowski
Perry Capital owns shares in King and, to facilitate approval of the merger, buys shares in Mylan, whilst hedging out its economic exposure to Mylan's share price using derivatives. The price at which Mylan proposes to merge with King is generous to King shareholders, but the merger does not look likely to be approved by Mylan shareholders, who must vote upon it. If Perry can swing the voting in favor of the deal, it will gain handsomely on its King shares without facing any corresponding losses on its Mylan holdings since those are hedged. Carl Icahn, another shareholder in Mylan, opposed the deal and sued Perry for alleged vote buying.

Keywords:
Business ethics, Finance, Investments, Litigation, Mergers & acquisitions, Stock valuation, Mylan Laboratories' Proposed Merger with King Pharmaceutical Case Solution

Click Here to place your order

OR

Contact us directly at ordercasesolutions@gmail.com if you want to solve the above case.